BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21647712)

  • 21. Frontotemporal dementia: therapeutic interventions.
    Mendez MF
    Front Neurol Neurosci; 2009; 24():168-178. PubMed ID: 19182475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease.
    Uflacker A; Edmondson MC; Onyike CU; Appleby BS
    Int Psychogeriatr; 2016 Feb; 28(2):269-73. PubMed ID: 26435062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-pharmacological management for patients with frontotemporal dementia: a systematic review.
    Shinagawa S; Nakajima S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K; Miller BL
    J Alzheimers Dis; 2015; 45(1):283-93. PubMed ID: 25737152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.
    Okumura Y; Togo T; Fujita J
    Int Psychogeriatr; 2015 Mar; 27(3):407-15. PubMed ID: 25213318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family caregivers of individuals with frontotemporal dementia: examining the relationship between coping and caregiver physical and mental health.
    Wong CC; Wallhagen MI
    J Gerontol Nurs; 2014 Jan; 40(1):30-40. PubMed ID: 24015887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregiver burden and needs in frontotemporal dementia.
    Diehl-Schmid J; Schmidt EM; Nunnemann S; Riedl L; Kurz A; Förstl H; Wagenpfeil S; Cramer B
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):221-9. PubMed ID: 23904354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition.
    Finger EC
    J Mol Neurosci; 2011 Nov; 45(3):696-701. PubMed ID: 21618004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: Modelling the pathology and behaviour of frontotemporal dementia.
    Solomon DA; Mitchell JC; Salcher-Konrad MT; Vance CA; Mizielinska S
    Neuropathol Appl Neurobiol; 2019 Feb; 45(1):58-80. PubMed ID: 30582188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontotemporal dementias: a review.
    Weder ND; Aziz R; Wilkins K; Tampi RR
    Ann Gen Psychiatry; 2007 Jun; 6():15. PubMed ID: 17565679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychocutaneous disease: Pharmacotherapy and psychotherapy.
    Kuhn H; Mennella C; Magid M; Stamu-O'Brien C; Kroumpouzos G
    J Am Acad Dermatol; 2017 May; 76(5):795-808. PubMed ID: 28411772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological agents to treat severe neuropsychiatric symptoms in major neurocognitive disorders.
    Mischel N; Rakesh G; Gupta S; Muzyk A; Masand P
    Ann Clin Psychiatry; 2020 May; 32(2):128-141. PubMed ID: 32343284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Coping Strategies in Psychological Outcomes for Frontotemporal Dementia Caregivers.
    Roche DClinPsy L; Croot K; MacCann C; Cramer B; Diehl-Schmid J
    J Geriatr Psychiatry Neurol; 2015 Sep; 28(3):218-28. PubMed ID: 26072312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.
    Banks SJ; Weintraub S
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):299-306. PubMed ID: 19776310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Underpinning Caregiver Burden in Frontotemporal Dementia Differ in Spouses and their Children.
    Kaizik C; Caga J; Camino J; O'Connor CM; McKinnon C; Oyebode JR; Piguet O; Hodges JR; Mioshi E
    J Alzheimers Dis; 2017; 56(3):1109-1117. PubMed ID: 28106550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism in frontotemporal dementias.
    Rowe JB
    Int Rev Neurobiol; 2019; 149():249-275. PubMed ID: 31779815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charting Frontotemporal Dementia: From Genes to Networks.
    Filippi M; Agosta F; Ferraro PM
    J Neuroimaging; 2016; 26(1):16-27. PubMed ID: 26617288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies.
    Boxer AL; Boeve BF
    Alzheimer Dis Assoc Disord; 2007; 21(4):S79-87. PubMed ID: 18090429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontotemporal dementia and pharmacologic interventions.
    Kaye ED; Petrovic-Poljak A; Verhoeff NP; Freedman M
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):19-29. PubMed ID: 20160206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontotemporal dementia.
    Devenney EM; Ahmed RM; Hodges JR
    Handb Clin Neurol; 2019; 167():279-299. PubMed ID: 31753137
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.